Noradox (Doxazosin Mesilate)

Doxazosin mesilate selectively blocks alpha‑1 adrenergic receptors on blood vessels and prostate smooth muscle. This blockade causes blood vessels to relax, reducing peripheral resistance and blood pressure, while also decreasing muscle tone in the prostate and bladder neck to ease urinary obstruction.

The appropriate dose of Noradox is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any other medications being taken. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for doxazosin mesilate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Noradox, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noradox belongs to the alpha‑1 blocker class, offering both blood‑pressure reduction and prostate smooth‑muscle relaxation. Compared with beta‑blockers, it does not affect heart rate, and unlike 5‑alpha‑reductase inhibitors, it provides quicker relief of urinary symptoms but does not shrink prostate size.

Noradox should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and keep them out of reach of children.

Noradox is taken orally, usually once daily with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include severe hypotension, syncope, heart failure worsening, and rare cases of priapism or allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, chest pain, persistent swelling, or any signs of an allergic response.

Noradox is contraindicated in patients with known hypersensitivity to doxazosin or any component of the formulation, and it should be used with caution in individuals with severe liver disease, uncontrolled heart failure, or a history of priapism. Pregnant or breastfeeding women should only use it if clearly indicated by a physician.